Allergan PLC. (AGN) Holdings Trimmed by 683 Capital Management LLC

Maricruz Casares
Diciembre 15, 2017

The quarterly performance for the stock is -24.35%, while the half-yearly performance is -27.91%. The company's outstanding shares are 55.14 Million. Edgewood Management LLC now owns 4,445,924 shares of the company's stock valued at $911,192,000 after buying an additional 869,248 shares during the period. Axa owned 0.15% of Allergan worth $100,068,000 at the end of the most recent reporting period.

A number of other brokerages also recently commented on AGN. Shelton Capital Management increased its stake in shares of Allergan by 35.4% during the 3rd quarter. A statistical measure of the dispersion of returns (volatility) for ATH producing salvation in Investors mouth, it has week volatility of 3.52% and for the month booked as 2.42%. LLC now owns 500 shares of the company's stock worth $122,000 after purchasing an additional 385 shares during the period. Finally, Brave Asset Management Inc. raised its stake in shares of Allergan by 25.9% in the third quarter. Hedge funds and other institutional investors own 81.34% of the company's stock. Royal Bank Of Canada increased their price target on shares of Allergan PLC. from $279.00 to $284.00 and gave the company an outperform rating in a report on Wednesday, May 10th.

AGN has been the topic of several research reports. They noted that the move was a valuation call. Analysts reported that the Price Target for Allergan plc might touch $280 high while the Average Price Target and Low price Target is $229.36 and $165 respectively. Allergan now has a consensus rating of "Buy" and a consensus price target of $235.25. Cantor Fitzgerald reiterated a "hold" rating on shares of Allergan in a report on Tuesday, August 29th.

Analyst's mean target price for company is $3.63 while analysts mean suggestion is 2.3. Argus lowered shares of Allergan from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $256.80 to $160.07 in a research note on Thursday, December 7th. The stock was acquired at an average price of $164.77 per share, for a total transaction of $499,253.10. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

More news: Gujarat: 'Karachi' flues more buzz over Modi's seaplane ride

In other Allergan news, insider William Meury sold 11,807 shares of Allergan stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $173.89, for a total value of $2,053,119.23. The disclosure for this sale can be found here. The consensus recommendation is the average rating on a stock by the analyst community. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders.

Based on a recent bid, the stock is trading -32.55% away from its 52-week high and 8.21% away from its 52 week low. Toth Financial Advisory has invested 0.06% in Allergan plc (NYSE:AGN). The stock's beta is 1.11 whilst the stock has an average true range (ATR) of 4.52. Over the long run, the price of a stock will normally go up in lock step with its earnings (assuming the P/E ratio is constant).

Allergan (NYSE:AGN) last announced its quarterly earnings results on Wednesday, November 1st. After $4.15 actual earnings per share reported by Allergan plc for the previous quarter, Wall Street now forecasts 14.22 % EPS growth. The business had revenue of $4.03 billion for the quarter, compared to the consensus estimate of $4.04 billion. The company reported the earnings of $4.15/Share in the last quarter where the estimated EPS by analysts was $4.06/share. Investors of record on Thursday, May 18th were given a $0.70 dividend. However, analysts' mean recommendation for this stock stands at 2.20. More interesting news about Allergan plc (NYSE:AGN) were released by: and their article: "Analyst Says Negative Allergan Headlines Are Priced In, Upgrades Stock" published on November 29, 2017 as well as's news article titled: "3 Big Stock Charts for Thursday: Allergan plc Ordinary Shares (AGN), Cummins ..." with publication date: May 11, 2017. Allergan's payout ratio is -12.44%. The stock exchanged hands with 2,224,209 numbers of shares compared to its average daily volume of 3.87M shares. This buyback authorization allows the company to purchase up to 2.8% of its shares through open market purchases. If you are viewing this article on another publication, it was stolen and republished in violation of United States and worldwide copyright legislation. The correct version of this news story can be accessed at

Otros informes por

Discuta este artículo